About

Peptides went from a research curiosity to a real market faster than anyone built the vocabulary to describe it. There is excellent clinical writing about individual molecules and there is an enormous amount of marketing. There is almost nothing in between that treats this as what it now is: an industry, with a supply chain, a regulatory perimeter, unit economics, and a set of people making consequential decisions inside it.

That gap is the show. Each week we sit down with one person who works somewhere real in this market and talk for as long as it takes — researchers, compounding pharmacists, telehealth and clinic operators, regulatory counsel, and the self-experimenters whose data keeps arriving years before the trials do.

Every episode is published in full, with a complete transcript. We don’t cut the parts where a guest hedges, disagrees with us, or says the honest thing is “we don’t know yet.” In a field this noisy, the hedges are most of the signal.